Grant: Doctoral Research Award: Canada Graduate Scholarships
McGill University
$105,000.00
Resolving the cis-regulatory role of the histone post-translational modification H3K36me2 in driving tumorigenesis
EF 2020-21
Résumé
Changes to the DNA sequence -- genetic mutations -- have long been recognized to play a critical role in causing crippling afflictions. In addition to directly hampering the function of a single gene with known functions and a straightforward link to disease, indirect but potentially more damaging paths also exist. For example, the process of reading DNA itself is non-trivial, as they are wrapped around structural proteins called histones to form compact fibres, which, through multiple levels of organization, ultimately adopt complex 3D shapes in order to fit 2 meter long strands within our tiny cells. As a result, modifications to DNA that do not alter its sequence and those to histones, altogether known as epigenetic marks, can dictate how much a gene is read and consequently the amount of its biologically functional products -- proteins.
We and others have discovered that certain epigenetic marks can stratify a number of heterogenous cancers into finer clinically distinct subtypes. Subsequently, we unveiled that some tumour subgroups are characterized by mutations to particular histone genes themselves or to epigenetic writers, demonstrating a convergence of downstream impacts. To do so, we applied gene editing and other techniques to mimic tumours in a dish, after which we subjected these models to a variety of epigenetic assays. Based on recent findings, we believe that perturbation of enhancer function can link epigenetic changes to eventual disease, with enhancers being DNA sequences that do not necessarily code for genes but can be brought in close proximity to activate genes for reading. We thus aim to supplement our previous epigenetic data with assays of 3D DNA organization to determine how enhancers' epigenetic marks and the way they fold onto other elements in 3D space contributes to cancer with specific epigenetic defects. These mechanistic insights will be crucial to improve our understanding of basic biology and inform therapeutic development.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
439495
Name
Hu Bo
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Resolving the cis-regulatory role of the histone post-translational modification H3K36me2 in driving tumorigenesis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Chromatin Conformation Capture; Cis-Regulation; Dna Methylation; Enhancer; Epigenetics; H3k36me2; Histone Modifications; Nuclear Architecture; Oncohistones; Tumorigenesis
Abstract
Changes to the DNA sequence -- genetic mutations -- have long been recognized to play a critical role in causing crippling afflictions. In addition to directly hampering the function of a single gene with known functions and a straightforward link to disease, indirect but potentially more damaging paths also exist. For example, the process of reading DNA itself is non-trivial, as they are wrapped around structural proteins called histones to form compact fibres, which, through multiple levels of organization, ultimately adopt complex 3D shapes in order to fit 2 meter long strands within our tiny cells. As a result, modifications to DNA that do not alter its sequence and those to histones, altogether known as epigenetic marks, can dictate how much a gene is read and consequently the amount of its biologically functional products -- proteins.
We and others have discovered that certain epigenetic marks can stratify a number of heterogenous cancers into finer clinically distinct subtypes. Subsequently, we unveiled that some tumour subgroups are characterized by mutations to particular histone genes themselves or to epigenetic writers, demonstrating a convergence of downstream impacts. To do so, we applied gene editing and other techniques to mimic tumours in a dish, after which we subjected these models to a variety of epigenetic assays. Based on recent findings, we believe that perturbation of enhancer function can link epigenetic changes to eventual disease, with enhancers being DNA sequences that do not necessarily code for genes but can be brought in close proximity to activate genes for reading. We thus aim to supplement our previous epigenetic data with assays of 3D DNA organization to determine how enhancers' epigenetic marks and the way they fold onto other elements in 3D space contributes to cancer with specific epigenetic defects. These mechanistic insights will be crucial to improve our understanding of basic biology and inform therapeutic development.
Competitiondate
202011
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Hu, Bo
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~